|
0
|
|
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.
(nature.com)
|
Safonov A
…
Razavi P
Nature
2026-04-01
|
#homologous recombination
#cancer
#brca2
#mutation
#amr
|
|
0
|
|
Ageing promotes metastasis via activation of the integrated stress response.
(nature.com)
|
Patel AAH
…
Sayin VI
Nature
2026-04-01
|
#metastasis
#cancer
#metabolism
#plasticity
#aging
|
|
0
|
|
A clinic-responder-derived defined microbial consortium enhances anti-PD-1 immunotherapy efficacy in mice.
(nature.com)
|
Zhou H
…
Yang C
Nature Microbiology
2026-04-01
|
#microbiome
#immunotherapy
#metagenomics
#cancer
#metabolism
|
|
0
|
|
In vivo site-specific engineering to reprogram T cells.
(nature.com)
|
Nyberg WA
…
Eyquem J
Nature
2026-04-01
|
#genome editing
#immunotherapy
#crispr
#cancer
#gene therapy
|
|
0
|
|
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial.
(nature.com)
|
Porcari S
…
Ianiro G
Nature Medicine
2026-04-01
|
#microbiome
#immunotherapy
#cancer
#transplantation
#dysbiosis
|
|
0
|
|
ZFTA-RELA ependymomas make itaconate to epigenetically drive fusion expression.
(nature.com)
|
Natarajan SK
…
Venneti S
Nature
2026-04-01
|
#metabolism
#epigenetics
#cancer
#virulence
|
|
0
|
|
Multi-Omics Analysis of Gut Microecological Variations in Colorectal Cancer.
(sfamjournals.onlinelibrary.wiley.com)
|
Yinhang W
…
Shuwen H
Environmental Microbiology
2026-04-01
|
#microbiome
#cancer
#metabolomics
#sequencing
#biomarker
|
|
0
|
|
High-content CRISPR activation screens identify synthetically lethal RNA-based mechanisms to sensitize cancer cells to targeted T cell cytotoxicity.
(nature.com)
|
Akana RV
…
Jerby L
Nature Genetics
2026-04-01
|
#crispr
#immunotherapy
#transcriptomics
#screening
#cancer
|
|
0
|
|
Widespread distribution of Alu/Alu-mediated genomic rearrangement predisposing to a broad range of Mendelian disease and cancer in human populations.
(link.springer.com)
|
Duan RV
…
Lupski JR
Genome Medicine
2026-04-01
|
#copy_number_variation
#mendelian disease
#genomic rearrangement
#cancer
#structural variation
|
|
0
|
|
On the shoulders of a giant: an appraisal of the legacy of Dr. Gerald P Bodey to infectious diseases.
(linkinghub.elsevier.com)
|
Kontoyiannis DP
…
Chemaly RF
Clinical Microbiology and Infection
2026-04-01
|
#immunocompromised
#infection
#neutropenia
#cancer
#amr
|
|
0
|
|
Thymic health and immunotherapy outcomes in patients with cancer.
(nature.com)
|
Bernatz S
…
Aerts HJWL
Nature
2026-04-01
|
#immunotherapy
#biomarker
#cancer
#immunity
#t cell
|
|
0
|
|
Real-world clinical utility of tumor whole-genome sequencing in solid cancers.
(nature.com)
|
van Putten J
…
Monkhorst K
Nature Medicine
2026-04-01
|
#sequencing
#cancer
#biomarker
#precision medicine
|
|
0
|
|
Dominant clones leverage developmental epigenomic states to drive ependymoma.
(nature.com)
|
Kardian AS
…
Mack SC
Nature
2026-04-01
|
#epigenomics
#cancer
#transcriptomics
#chromatin
|
|
0
|
|
Identification of non-canonical peptides with moPepGen.
(nature.com)
|
Zhu C
…
Boutros PC
Nature Biotechnology
2026-04-01
|
#proteogenomics
#proteomics
#transcriptomics
#cancer
#modeling
|
|
0
|
|
Harnessing genomics for early cancer detection, risk stratification and prevention.
(nature.com)
|
Gu M
…
Vassiliou GS
Nature Genetics
2026-04-01
|
#cancer
#genomics
#screening
#methylation
#mutation
|
|
0
|
|
GCN5-ERK lactylation-phosphorylation loop amplifies lactate-driven cancer progression.
(nature.com)
|
Huang B
…
Zhong C
Nature Chemical Biology
2026-04-01
|
#cancer
#metabolism
#signaling
#virulence
|
|
0
|
|
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial.
(nature.com)
|
Wainberg ZA
…
O'Reilly EM
Nature Medicine
2026-04-01
|
#immunotherapy
#cancer
#chemotherapy
#clinical trial
#biomarker
|
|
0
|
|
Global and regional cancer burden attributable to modifiable risk factors to inform prevention.
(nature.com)
|
Fink H
…
Soerjomataram I
Nature Medicine
2026-04-01
|
#cancer
#prevention
#epidemiology
#risk_factors
|
|
0
|
|
eIF3 musketeers: loyal in health, rogue in disease, and redeemed by therapeutic targeting.
(link.springer.com)
|
Mohammadinejad R
…
Wolf DA
The EMBO Journal
2026-04-01
|
#translation
#therapeutics
#cancer
#neurodegeneration
#infection
|
|
0
|
|
Colonoscopy and fecal immunochemical testing versus usual care in diagnostic colorectal cancer screening: the SCREESCO randomized controlled trial.
(nature.com)
|
Westerberg M
…
Forsberg A
Nature Medicine
2026-04-01
|
#screening
#colonoscopy
#cancer
#randomized controlled trial
|
|
0
|
|
Selenoprotein P deficiency drives hepatocellular carcinoma progression via induction of neutrophil senescence and immunosuppressive microenvironment.
(gut.bmj.com)
|
Jiao J
…
Zhan L
Gut
2026-04-01
|
#cancer
#immunity
#metabolism
#senescence
#transcriptomics
|
|
0
|
|
Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma.
(nature.com)
|
Zhang J
…
Taylor MD
Nature
2026-04-01
|
#ependymoma
#androgen
#cancer
#differentiation
|
|
0
|
|
The integrated stress response promotes immune evasion through lipocalin 2.
(nature.com)
|
Bossowski JP
…
Papagiannakopoulos T
Nature
2026-04-01
|
#immunotherapy
#cancer
#immunity
#immunosuppression
#metabolism
|
|
0
|
|
SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer.
(nature.com)
|
Li B
…
Veillette A
Nature
2026-04-01
|
#immunotherapy
#t cell
#cancer
#checkpoint
#exhaustion
|
|
0
|
|
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours.
(nature.com)
|
Yang L
…
Chen S
Nature
2026-04-01
|
#immunotherapy
#engineering
#cancer
#cytotoxicity
#crispr
|
|
0
|
|
Epigenetic memory of colitis promotes tumour growth.
(nature.com)
|
Nagaraja S
…
Buenrostro JD
Nature
2026-04-01
|
#epigenetics
#colitis
#cancer
#inflammation
#transcriptomics
|
|
0
|
|
Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.
(nature.com)
|
Huang Z
…
Zhang Y
Nature Medicine
2026-04-01
|
#immunotherapy
#cancer
#chronotherapy
#clinical trial
#chemotherapy
|
|
0
|
|
Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trial.
(nature.com)
|
Fernandes R
…
Maleki Vareki S
Nature Medicine
2026-04-01
|
#microbiome
#immunotherapy
#cancer
#transplantation
#immunity
|
|
0
|
|
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma.
(nature.com)
|
Lv J
…
Sun Y
Nature
2026-04-01
|
#ctdna
#biomarker
#cancer
#chemotherapy
#prognosis
|
|
0
|
|
AI-based triage and decision support in mammography and digital tomosynthesis for breast cancer screening: a paired, noninferiority trial.
(nature.com)
|
Elias-Cabot E
…
Alvarez-Benito M
Nature Medicine
2026-04-01
|
#screening
#cancer
#ai
#imaging
#automation
|
|
0
|
|
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.
(nature.com)
|
Duttagupta S
…
Elkrief A
Nature Medicine
2026-04-01
|
#microbiome
#immunotherapy
#metagenomics
#cancer
#immunity
|
|
0
|
|
Multidimensional profiling of heterogeneity in supratentorial ependymomas.
(nature.com)
|
Jeong D
…
Filbin MG
Nature
2026-04-01
|
#transcriptomics
#cancer
#heterogeneity
#single-cell
|
|
0
|
|
A small-molecule inverse agonist of PPARgamma for advanced solid tumors: a phase 1 trial.
(nature.com)
|
Galsky MD
…
Gao X
Nature Medicine
2026-04-01
|
#cancer
#drug
#clinical trial
#toxicity
|